Hair Relaxer Lawsuit: News and Updates

Nguyen Injury Lawyer is actively investigating hair relaxer cancer lawsuits across the country. This page offers:

• Up-to-date news and information on litigation involving chemical hair relaxers.
• Analysis from our attorneys regarding the potential trajectory of these lawsuits.
• An insider’s perspective on developments in the litigation.
• Our projections for potential settlement amounts in these cases.

We are particularly interested in representing women who have been diagnosed with:

• Uterine cancer
• Endometrial cancer
• Ovarian cancer
• Uterine fibroids
• Had a hysterectomy due to fibroids

Our attorneys are committed to fighting for maximum compensation for women who have suffered harm from chemical hair straighteners. Contact Nguyen Injury Lawyer today at XXX-XXX-XXXX for a free consultation, or reach us through our website: https://www.nguyeninjurylawyer.com/contact.

Hair Relaxer Class Action Lawsuit Update

Nguyen Injury Lawyer is dedicated to providing the latest news, updates, and information on hair relaxer lawsuits. Please bookmark this page for future reference.

MDL Case Count

March 17, 2026: The hair relaxer MDL now includes 11,440 plaintiffs.

Expert Discovery Developments

March 9, 2026: The recent status hearing indicated a shift toward the expert phase of the hair relaxer MDL. Discussions focused on refining the key issues and establishing guidelines for expert testimony, which will significantly influence the litigation.

Judge Rowland urged both sides to streamline the case by agreeing on basic factual stipulations related to marketing, advertising, labeling, warnings, and product instructions. The court wants to avoid wasting time on undisputed facts and encouraged lawyers to resolve these matters independently, involving the court only when necessary.

The court also outlined the process for upcoming Daubert challenges, which are motions to exclude expert testimony. These motions are crucial, as the party that prevails during the Daubert stage often gains leverage in settlement negotiations. Judge Rowland allowed flexibility in filing formats but set clear page limits. The defendants have 100 pages to challenge the plaintiffs’ ten experts, while the plaintiffs can respond with either a single 100-page brief or ten separate responses of ten pages each. The defendants will then have 50 pages for a reply. The judge also instructed the plaintiffs to coordinate with the defense regarding challenges to the defendants’ experts, suggesting that these motions will follow soon after.

Another issue involved RNA Corporation, a defendant in the MDL. The parties must report by April 23 whether the plaintiffs will agree to pause discovery against that company. Until that decision is made, any discovery disputes related to RNA will be handled by Magistrate Judge Jantz. This is standard procedure in MDL cases, aimed at preventing discovery disputes from slowing down the main litigation.

Judge Rowland also addressed the issue of plaintiffs who have not properly served their short-form complaints. The court will issue orders requiring these plaintiffs to correct the problem or risk dismissal of their cases with prejudice. Judges overseeing large MDLs often become stricter about administrative matters as the case progresses to separate valid claims from cases with incomplete paperwork.

Discovery Battle Over Corporate Witnesses

March 4, 2026: The next legal battle in the hair relaxer MDL concerns whether the companies that sold these products will be required to provide sworn testimony regarding their marketing practices.

The plaintiffs aim to depose corporate representatives on topics such as warnings, labeling, marketing, and advertising related to specific plaintiffs and geographic markets. These depositions compel a company to designate a witness who can speak on behalf of the corporation, securing testimony about the company’s knowledge, consumer communications, and product promotion strategies.

The defendants have proposed replacing these depositions with written stipulations, where the companies would agree to certain limited facts on paper instead of providing a corporate witness. The plaintiffs considered stipulations only after the defense suggested a “global” approach applicable to multiple bellwether plaintiffs. The plaintiffs then drafted proposed stipulations covering marketing, warnings, and labeling across the bellwether cases and sent them to several defendants in late February. If an agreement is reached, the stipulations could replace some corporate depositions; otherwise, the plaintiffs intend to proceed with the depositions to secure trial testimony.

Corporate depositions often reveal crucial details about a product, allowing plaintiffs to question internal decisions regarding warnings, risk communication, and marketing strategies. Written stipulations, on the other hand, tend to sanitize the narrative by presenting a limited set of agreed facts without exposing witnesses to in-depth questioning.

New Discovery Dispute

February 16, 2026: A recent discovery dispute in the Avlon litigation involves former employee Tom Bingham’s separation from the company. Judge Beth W. Jantz reviewed Bingham’s separation agreement in camera after the plaintiffs argued that defense counsel improperly used the agreement’s confidentiality provisions to obstruct questioning during his deposition. The judge directed the plaintiffs to identify specific portions of the transcript where they sought to explore the circumstances of Bingham’s departure but were stopped due to objections related to the separation agreement. The plaintiffs have now filed a notice listing multiple page-and-line citations where they allege the defense curtailed the inquiry into the reasons for his exit.

The core issue is whether a private separation agreement can be used to limit a witness’s testimony in federal litigation. By examining the agreement herself, Judge Jantz is assessing whether the defense objections were justified or whether further testimony should be compelled. The dispute does not address the merits of the underlying claims but reflects ongoing tension over the scope of discovery, particularly when former employees and potentially sensitive internal matters are involved.

Case Count

February 10, 2026: The hair relaxer MDL now includes 11,105 plaintiffs.

Latest Update

February 3, 2026: While progress may seem slow, particularly for those awaiting resolution of their specific cases, the litigation is actively advancing. There are now 11,195 plaintiffs in the MDL, with over 99% of those cases currently on hold pending the resolution of the bellwether cases.

The defendants have deposed 29 of the 32 bellwether plaintiffs, with the remaining three scheduled for early February.

The defendants are seeking additional time to depose numerous third-party witnesses, including doctors, hairstylists, and family members. Ninety-three subpoenas have been issued, but fewer than half have confirmed dates. The defendants are requesting a brief extension beyond the February 16 discovery cutoff to gather sufficient information for selecting cases to proceed to trial, emphasizing that this is not intended as a delay but rather to ensure informed bellwether choices.

The plaintiffs argue that the defendants waited too long, issued notices too late, refused to conduct remote depositions, and are now seeking court intervention to resolve a self-inflicted problem. From the plaintiffs’ perspective, extending discovery across all 32 bellwether cases is unnecessary when most of these cases will not go to trial, placing undue burden on doctors and third parties with minimal gain and undermining the purpose of a structured bellwether process.

Additionally, a discovery dispute is emerging regarding corporate testimony. The plaintiffs are seeking limited Rule 30(b)(6) depositions related to specific products, years, and geographic markets relevant to individual bellwether plaintiffs. The defendants contend that this is a disguised attempt to reopen general discovery, while the plaintiffs argue that it is necessary to determine which advertisements a woman saw or what warnings were present when and where she used the product.

The plaintiffs are urging the court to set a trial date, while the defendants are resisting, deeming it premature to discuss 2027. This resistance is telling.

Outside the MDL, state court cases are progressing. Illinois is planning cohort trials in late 2026 and early 2027. The Georgia Supreme Court has ruled in favor of the plaintiffs on a statute-of-repose issue. Discovery is underway in New York, and Philadelphia is organizing its cases.

Defendants

January 6, 2026: Nguyen Injury Lawyer is focusing on lawsuits against the following defendants:

• Dark & Lovely, Ultra Sheen, etc. (L’Oréal, the primary defendant, valued at nearly $225 billion)
• ORS Olive Oil Hair Relaxer (Namaste, LLC)
• Just for Me (TCB Naturals/Godrej Consumer Products)
• Motions (Strength of Nature Global, LLC)
• Revlon (currently in bankruptcy but believed to have sufficient insurance coverage for chemical hair straightener claims)

Our attorneys are also reviewing cases involving Optimum Salon and other hair perm and hair straightener products.

When Will the Hair Relaxer Lawsuit Be Settled?

January 4, 2026: Despite some delays in the bellwether schedule, discovery in the federal Hair Relaxer MDL is progressing. Depositions are ongoing, expert work is advancing, and the cases are moving through the typical mass tort process. However, these steps have not yet created significant pressure for settlement.

This is largely because the defendants do not yet face the imminent threat of a trial, which typically drives settlement discussions in mass tort litigation.

Trial dates are transformative. When companies face the possibility of a jury trial within months, the risk becomes tangible, leading to internal reassessments and often unlocking settlement authority. However, with the first trial still distant, the defendants can afford to wait. This is the current situation in this litigation.

The next critical juncture will be the court’s rulings on expert challenges, which will determine the admissible evidence at trial. We are confident in our chances of success in these challenges. Once the scope of evidence is defined, realistic settlement negotiations can begin. However, these decisions are not expected until late 2026 based on the current schedule.

The underlying cases are strong, which is encouraging for the plaintiffs. The epidemiological evidence linking long-term use of chemical hair relaxers to uterine cancer continues to gain traction, and the bellwether plaintiffs have compelling stories of injury. The defendants face considerable risk in allowing even one of these cases to reach a jury.

MORE Hair Relaxer Lawsuit Updates

December 9, 2025: Hair Relaxer Lawsuits Continue to Grow

If you believe you have a case, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or through our website: https://www.nguyeninjurylawyer.com

Hair Relaxer MDL Growth and Case Updates

At one point, the hair relaxer class action MDL was seeing thousands of new cases added monthly. While the pace has slowed, the MDL continues to expand. In November, 121 new cases were added, bringing the total number of plaintiffs to 10,844.

Strong Exposure Cases: Hair Relaxer Lawsuits from Salon Workers

October 2, 2025

Some of the most compelling hair relaxer lawsuits being filed involve professional stylists and cosmetologists. These women have a history of working with chemical straighteners daily for years, applying them to clients and handling the products in enclosed salon environments.

Case Dismissals for Non-Compliance

September 29, 2025

During Friday’s MDL hearing, Judge Mary Rowland ruled on several defense requests to dismiss cases for noncompliance with CMO 9. One case was dismissed with prejudice, while others were dismissed without prejudice but could be refiled by year-end if plaintiffs refile in the MDL and promptly submit complete plaintiff fact sheets and authorizations.

Two plaintiffs were ordered to file status reports by the next day, confirming compliance, or face dismissal with prejudice. Another plaintiff’s case was dismissed with prejudice for repeated failures to appear and prosecute, despite prior warnings. One plaintiff was given until October 30 to remedy deficiencies, with the same December 30 deadline for refiling or face dismissal with prejudice.

While dismissing plaintiffs who cannot or will not comply with court requirements may seem harsh initially, it ultimately strengthens the litigation for everyone else. A cleaner docket means the true case count is clear, which is essential when negotiating a global chemical hair relaxer settlement.

Discovery Scheduling and Status Hearing

September 17, 2025

Following the status hearings on September 4 and 8, the court issued a detailed order outlining new deadlines, instructions, and rulings, including a possible extension of the oral discovery schedule. Parties must file a joint update by September 24 on deposition progress, including an updated chart of all scheduled or completed depositions. Another in-person hearing is scheduled for October 9 before Judge Rowland.

New Order Following Status Conference

September 11, 2025

Judge Rowland is progressing the Hair Relaxer MDL with deadline management and procedural steps, offering insight into how she intends to manage this litigation involving over 10,000 plaintiffs.

The judge extended the deadline for plaintiffs’ expert disclosures related to general causation to December 1. Defendants have until January 6, 2026, to serve their reports, with rebuttals from plaintiffs due January 20. This timeline adjustment indicates Judge Rowland’s flexibility while keeping the focus on scientific evidence.

Science Day remains set for January 8, with strict rules on rebuttal report content.

Notably, the judge is maintaining pressure on deposition progress. While considering plaintiffs’ attorneys’ request to extend the oral discovery schedule, she ordered a joint update from both sides by September 24 to report on deposition progress. This maintains pressure and keeps the litigation on track.

The court also addressed logistical cleanup, noting orders for cases with duplicate filings or unresolved substitution motions, common in MDLs of this size but important for progress.

The expert discovery cutoff and Daubert briefing schedule (March 2 and April 1, respectively) serve as a reminder that the window for developing general causation and challenging defense theories on scientific grounds is approaching.

Insurance Coverage Matters

September 5, 2025

Sally Beauty Holdings Inc. has sued Cincinnati Insurance Co. and Cincinnati Casualty Co. in Texas federal court, alleging breached coverage obligations by failing to fully cover defense costs in hair relaxer lawsuits.

While Cincinnati initially agreed to defend Sally Beauty and approved lawyers, the insurer has only reimbursed a fraction of expenses, forcing the company to cover most of its own defense.

Nguyen Injury Lawyer supports Sally Beauty in this insurance dispute because every dollar recovered from Cincinnati benefits plaintiffs in the underlying hair relaxer litigation. When insurers fulfill their obligations, companies like Sally Beauty can allocate more resources to settlement funds for injured women. Coverage disputes like these are technical, but the outcome significantly impacts potential recoveries for plaintiffs.

Problems with Avlon

September 4, 2025

Deposition scheduling is becoming a key point of contention in the litigation. Plaintiffs’ lawyers are frustrated by the limited time to review newly produced documents before examining key witnesses.

One issue involves Ned Washington, Avlon’s former Worldwide Director of Sales, who oversaw global sales operations for over two decades. Plaintiffs argue that his deposition was compromised when Avlon produced hundreds of emails from his personal account shortly before his scheduled testimony. This late disclosure deprived them of a fair opportunity to review the material and prepare meaningful questions.

Plaintiffs’ lawyers are also frustrated with Avlon’s strategy of blending fact witness testimony with Rule 30(b)(6) depositions. Under Rule 30(b)(6), a company must designate a representative to testify about specific topics on its behalf, and that testimony is binding on the corporation. Plaintiffs insist this testimony must be kept separate from personal testimony, as they serve distinct legal and procedural functions.

Avlon’s discovery tactics have become deliberately obstructive. Its witnesses now refuse to authenticate their own emails, declining to confirm the authenticity of documents they sent or received. These are internal records produced by Avlon, not external materials or disputed evidence. This is a delay tactic employed by defense counsel to prioritize form over substance.

Science Day Scheduled

September 1, 2025

Judge Rowland has scheduled a science day for January 8, 2026. While formally a non-adversarial proceeding, its strategic importance is clear to everyone involved. Officially, the goal is to educate the court on the complex scientific and medical issues at the heart of the litigation. Unofficially, it is a carefully prepared preview of the expert battles to come, with each side aiming to shape how the court understands the science before Daubert motions or dispositive briefs are filed.

The format is straightforward. Plaintiffs will present their experts in the morning, outlining the research linking chemical hair relaxers to uterine cancer, fibroids, and other hormone-related injuries. The defense will respond in the afternoon, seeking to introduce uncertainty, alternative explanations, and statistical counterpoints. There is no testimony under oath, no cross-examination, and no rulings. However, the presentations are carefully curated, and the messaging is strategic.

Judge Rowland may engage directly with the experts, asking questions that reveal her priorities. Judges from related state court actions may also attend, seeking cues that could influence their own proceedings. While science day is not binding, it is significant. It sets the tone for how the court will process expert testimony, and for plaintiff counsel, it is an early and critical opportunity to define the scientific landscape on their terms. If you have questions about hair relaxer lawsuits, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit our website at https://www.nguyeninjurylawyer.com. You can also reach us through our contact page at https://www.nguyeninjurylawyer.com/contact.

New Connecticut Lawsuit

August 17, 2025

Plaintiffs continue to file new lawsuits in the Hair Relaxer MDL. On Friday, a Connecticut resident filed a lawsuit alleging that nearly four decades of using chemical hair relaxers, beginning before 1980 and ending around 2020, led to her diagnosis of uterine cancer in 1988.

The complaint names several well-known defendants, including L’Oréal, Revlon, SoftSheen-Carson, and Strength of Nature, accusing them of manufacturing and marketing products like Dark and Lovely, Just for Me, and Revlon Realistic without adequate warnings about their risks.

MDL Continues to Grow

August 3, 2025

The hair relaxer MDL now includes 10,567 pending cases before Judge Rowland in the Northern District of Illinois. This represents an increase of 285 cases from the 10,282 reported on July 1, reversing the previous month’s decline and indicating that the litigation may have more momentum than initially anticipated. As is common in maturing mass tort dockets, the monthly count reflects a combination of new filings and administrative actions, including the voluntary dismissal of weaker claims and the consolidation of overlapping actions.

This increase confirms that the litigation remains active as it progresses toward a more complex pretrial phase. Many women who used chemical hair straighteners for years are only now connecting their hormone-related cancers to prolonged exposure to these products. The latent nature of conditions like uterine and ovarian cancer suggests that filings are likely to continue, although at a slower pace.

The growing case count indicates that the MDL is still expanding while discovery proceeds. Although no bellwether trials have been scheduled yet, the court and the parties are moving toward a more defined procedural roadmap. The next phase will likely focus on expert discovery and challenges to general causation. The steady increase in filings suggests continued momentum for plaintiffs and emphasizes the need for thorough case development as the year progresses. If you believe you have a claim, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit our website at https://www.nguyeninjurylawyer.com. You can also reach us through our contact page at https://www.nguyeninjurylawyer.com/contact.

Philadelphia Chemical Relaxer Lawsuits Consolidated

June 23, 2025

The Philadelphia Court of Common Pleas has formally coordinated dozens of lawsuits into a consolidated mass tort program focused on hair relaxer products in Pennsylvania state court.

The court’s complex litigation center is now managing these cases as a unified docket, streamlining discovery and pretrial proceedings. Approximately 25 cases have been formally included in the program.

However, our attorneys anticipate that number to increase. Philadelphia is an attractive venue for these claims. Given the volume of mass torts already litigated in Philadelphia, such as those involving Paraquat and Roundup, the city offers a plaintiff-accessible venue with a track record of significant outcomes for deserving victims.

Coordinated proceedings are also underway in Georgia and New York, along with the federal hair relaxer MDL in the Northern District of Illinois.

Statute of Repose Battle in Georgia

June 22, 2025

Georgia’s Supreme Court is deciding whether individuals harmed by long-term use of products like chemical hair relaxers can still sue if more than 10 years have passed since they first used the product. This revolves around a statute of repose, which sets a strict time limit on filing a lawsuit, regardless of when the injury appears. In Georgia, that limit is 10 years from the product’s initial sale for use.

If you have questions about hair relaxer lawsuits, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit our website at https://www.nguyeninjurylawyer.com. You can also reach us through our contact page at https://www.nguyeninjurylawyer.com/contact.

The Significance of Exposure Levels for Stylists

A critical aspect often overlooked is that injuries from repeated chemical exposure, like hormone-linked cancers or uterine fibroids, may not manifest immediately. If the statute of limitations begins upon initial product use, individuals who have used a product for many years could be barred from filing suit simply because the harm took time to develop. This would allow companies to continuously sell potentially harmful products without accountability for the cumulative damage. For products like hair relaxers that cause harm over time, the law must consider actual usage patterns, not just the initial purchase date. UPDATE: We won this battle

Many stylists spent years consistently using, handling, and inhaling relaxer products. This level of sustained, occupational exposure means they absorbed significantly higher amounts of endocrine-disrupting chemicals than typical consumers, increasing their risk. This is particularly relevant in cases of hormone-related cancers, like uterine, ovarian, and breast cancer.

From both legal and scientific perspectives, this high-frequency contact is crucial. Proving that chemical hair straighteners caused cancer depends heavily on the amount and duration of exposure. For stylists who used these products for 8–10 hours daily throughout their careers, the argument for causation becomes much stronger. These claims are among the most compelling within the hair relaxer MDL litigation.

The harm extends beyond physical injuries. Many stylists built successful careers in cosmetology, only to lose everything after a cancer diagnosis or reproductive health issue. Unlike consumers, stylists often cannot simply avoid future exposure and return to work. They have lost not only their health but also their livelihoods, with some facing permanent complications from hysterectomies or aggressive cancer treatments. This all stems from manufacturers failing to warn them that daily work with these products could be life-threatening. If you are a stylist harmed by hair relaxers, contact Nguyen Injury Lawyer at XXX-XXX-XXXX or visit our website at https://www.nguyeninjurylawyer.com. You can also reach us through our contact page: https://www.nguyeninjurylawyer.com/contact.

Update on Philadelphia Litigation

June 2, 2025

The Philadelphia Court of Common Pleas recently established a new mass tort program for lawsuits related to chemical hair relaxers, enabling plaintiffs to pursue cancer claims linked to long-term use of straighteners and texturizers.

While the Philadelphia program currently involves a limited number of cases, it provides a structured and potentially quicker alternative to the MDL in Illinois.

For hair relaxer attorneys, Philadelphia offers strategic advantages over the MDL. The state court system is known for its efficient case management and ability to expedite complex product liability cases towards trial, often avoiding the procedural delays common in federal courts. With fewer cases on the docket, judges can focus more on individual claims, potentially leading to earlier trial dates and significant progress. The procedural flexibility in state court also appeals to hair relaxer lawyers, offering greater control over litigation strategies.

Additionally, Philadelphia juries are known to be fair to plaintiffs, particularly in cases involving corporate misconduct and consumer safety. This reputation, combined with the court’s readiness to conduct trials and a smaller, more manageable docket, makes Philadelphia an increasingly attractive venue for lawyers seeking to avoid MDL bottlenecks and pressure defendants through state-level bellwether trials. Nguyen Injury Lawyer is closely monitoring these developments.

Appointment of Settlement Mediator

April 30, 2025

The court issued Case Management Order No. 17, appointing Ellen K. Reisman as a Special Master to oversee and coordinate settlement negotiations in this litigation.

Such appointments are common in large MDLs and should not be interpreted as a sign that a settlement is imminent or even likely. The judge emphasized that this is a routine measure to manage complex litigation efficiently, especially with multiple parties, varying claims, and overlapping issues.

The Special Master’s appointment does not guarantee successful or even meaningful settlement talks. Success depends on the parties’ willingness to engage. While it is an encouraging development, its impact remains to be seen. Nguyen Injury Lawyer remains cautiously optimistic.

Hair Relaxer Settlement Talks on the Horizon

February 11, 2025

Negotiations in the Hair Relaxer MDL are progressing as plaintiffs and defendants move closer to settlement discussions.

While plaintiffs’ lawyers are remaining reserved, there is a general desire to see these lawsuits settled and provide victims with justice. Plaintiffs are keen to discuss potential mediators but are resisting defendants’ demands to outline a structured mediation process at this stage.

Defense lawyers argue that before meaningful settlement talks can begin, plaintiffs must provide a detailed theory of liability for each defendant’s role in the alleged injuries, proposing an exchange of case theories within 45 days of selecting a mediator. However, the key is to select a mediator and determine whether an agreement on settlement amounts can be reached before a bellwether trial.

Despite procedural disagreements, both sides appear to agree on a March 20, 2025, deadline to finalize mediator selections. If successful, this could pave the way for early-stage settlement discussions in this complex and high-stakes resolution process.

The coming weeks will be crucial in determining whether negotiations gain momentum or whether prolonged litigation, including bellwether trials, becomes inevitable. The next key update is expected following the March 27, 2025, Case Management Conference.

Are we optimistic about a hair relaxer settlement in the next few months? Not particularly. While we would like to be wrong, history suggests that it is difficult to reach a deal until closer to a trial date. Nguyen Injury Lawyer remains prepared for all possibilities.

MDL Trial Schedule Outlined

February 2, 2025

Judge Rowland has outlined a comprehensive bellwether trial plan for the hair relaxer MDL:

Date	Event
April 30, 2025	Parties identify and exchange 20 Initial Bellwether Discovery Cases.
May 9, 2025	Parties file joint status reports identifying Initial Bellwether Discovery Cases.
June 9, 2025	Each Defendant serves its Answer and Affirmative Defenses to Initial Bellwether Discovery Cases.
September 30, 2025	Close of oral fact discovery in the MDL.
October 31, 2025	Plaintiffs disclose general causation expert reports.
December 1, 2025	Defendants disclose general causation expert reports.
February 16, 2026	Close of case-specific fact discovery. Deadline for parties to file position papers on cases for trial selection.
March 2, 2026	Close of general causation expert discovery. Court to rule on Bellwether Trial Case selection.
April 1, 2026	Deadline to file general causation Daubert motions.
May 1, 2026	Close of additional case-specific fact discovery for Bellwether Trial Cases.
June 30, 2026	Plaintiffs disclose case-specific and all other expert reports.
August 3, 2026	Defendants disclose case-specific and all other expert reports.
October 16, 2026	Close of case-specific and all other expert discovery.
November 16, 2026	Deadline to file summary judgment and non-general causation Daubert motions.
January 6, 2027	Replies in support of summary judgment motions due.

Trials in the MDL are not expected until 2027, which is undoubtedly frustrating for victims seeking justice. However, trials may proceed in state court before this schedule. Significant verdicts in state court could prompt L’Oréal and other defendants to consider settlement. Nguyen Injury Lawyer is prepared to pursue justice through all available avenues.

Key Directives for Bellwether Trials

Bellwether Trials:

The judge is seeking a larger pool of cases for the bellwether trials. Initially, both parties agreed to select 16 cases for bellwether discovery, with five proceeding to trial. The judge has increased this to 40 cases for discovery, with the aim of having up to 12 proceed to trial.

Eligibility Criteria:

To streamline the selection process, the judge’s order defines “Eligible Cases” as those where plaintiffs have filed and served short-form complaints by February 1, 2024. Only cases involving specific injuries—namely, uterine, endometrial, or ovarian cancer—will be considered for the bellwether pool, narrowing the pool to approximately 5,230 cases.

Selection Process:

Each party is tasked with selecting 20 cases for bellwether discovery.

General Causation Discovery:

The court has approved a continued parallel approach, allowing expert discovery on general causation to proceed alongside case-specific discovery.

Substitution of Settled Cases:

In cases where a bellwether discovery case settles before trial selection, the plaintiffs have the authority to select a replacement case unilaterally. This is a common MDL rule.

MDL Assessment on Recoveries

December 4, 2024

The MDL has established an 11% assessment on gross monetary recoveries to compensate the attorneys working on behalf of all plaintiffs. This assessment is divided into 8% for legal fees and 3% for expenses. The legal fees portion is intended to reward the MDL attorneys for their significant efforts in advancing the litigation, including managing discovery, retaining experts, preparing for bellwether trials, and coordinating the overall case strategy. The expenses portion reimburses the costs associated with these activities, such as deposition fees, expert analyses, and document storage.

For plaintiffs, this means that a portion of any settlement or judgment they receive will go toward funding the common benefit work performed by the MDL attorneys. However, this will most likely come out of your lawyer’s fee, not your hair relaxer settlement. Nguyen Injury Lawyer is committed to transparency in all financial matters.

Uterine Fibroid Claims

November 5, 2024

Nguyen Injury Lawyer is once again accepting uterine fibroid claims. We have signed up hundreds of these claims in recent months.

We believe these lawsuits will ultimately have settlement value. If you have a case, please contact us at XXX-XXX-XXXX or visit our website at https://www.nguyeninjurylawyer.com. You can also reach us through our contact page: https://www.nguyeninjurylawyer.com/contact. However, it is important to understand that these cases are unlikely to receive the same settlement payouts as cancer claims involving hair relaxers.

Hair Relaxer Lawsuits in State Court

October 24, 2024

While the focus is often on the MDL class action, numerous hair relaxer lawsuits are also proceeding in state courts. Here’s a summary of the state and international court actions:

Cook County, Illinois:

Fifty-seven cases have been filed, with forty-four consolidated before Judge Patrick T. Stanton for motion practice and discovery. Four bellwether cases have completed briefing on motions to dismiss, with rulings pending. A discovery stay is in place until these rulings. Five cases may be set for trial in early 2026. Thirteen cases are still pending consolidation, which is on hold until after the August 28 hearing.

Georgia State Cases:

Twenty cases in Chatham County have been consolidated before Judge Derek J. White but are stayed pending an appeal in the Burroughs v. L’Oreal USA, Inc. case, which involves a statute of repose issue. Seven cases are pending in DeKalb County, with ongoing briefing on motions to dismiss. Plaintiffs seek to consolidate these cases under Judge Alvin T. Wong.

New York State Cases:

Two active cases are in New York County, with motions to dismiss pending.

Pennsylvania State Cases:

Updates on Hair Relaxer Lawsuits

Currently, six cases are being heard in the Court of Common Pleas in Philadelphia County, with ongoing discussions regarding pleading challenges. It is anticipated that many more cases will be filed in Philadelphia. (2025 Update: This litigation has been consolidated and has significantly expanded since this was initially written.)

Canadian Cases

In Canada, there are two potential class action lawsuits pending, but no motions for class certification have been submitted yet.

Answers to Common Hair Relaxer Lawsuit Questions

What’s the Latest on the Hair Relaxer MDL?

As of 2026, the hair relaxer MDL includes almost 15,000 filed cases. Defendants, such as L’Oréal and Revlon, are actively trying to delay proceedings, but the plaintiffs are aggressively moving forward. Judge Rowland has established a clear timeline leading up to bellwether trials. Unfortunately, these trials in the MDL are not scheduled to begin until 2027.

State court claims may progress more quickly, potentially leading to earlier settlement discussions than the 2027 trial date suggests. Currently, we are engaged in pre-trial discovery disputes, the accumulation of scientific evidence, and a growing number of claims that highlight the undeniable connection between chemical hair straighteners and hormone-related cancers. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX for a free consultation.

When Will the Hair Relaxer Lawsuit Be Settled?

As previously mentioned, trial dates often lead to settlements, especially in mass tort claims. Currently, the defendants are stalling, hoping that the cases will lose momentum. However, with trials scheduled for 2027, and possibly sooner in state courts, a settlement is likely as the trial date approaches. Our attorneys at Nguyen Injury Lawyer are optimistic about these cases and would like to report that a hair relaxer settlement update is imminent. However, we likely still have some time to go before a settlement is reached.

What Makes These Cases Stronger Than Some Other Product Liability Lawsuits?

Two key factors contribute to the strength of these cases: exposure and causation. Many personal injury cases fail because plaintiffs cannot demonstrate significant exposure to a dangerous product. This is not an issue in hair relaxer lawsuits. Millions of Black women have used these products for decades, and cosmetologists and hairstylists have experienced even higher levels of exposure. This makes these cases among the most compelling in product liability history. Consistent, long-term exposure to carcinogens makes proving causation much easier compared to cases with limited or sporadic exposure.

Why Are Hair Stylists Filing Some of the Strongest Relaxer Lawsuits?

Some of the most compelling relaxer lawsuits that Nguyen Injury Lawyer is currently seeing come from hairstylists and cosmetologists. This is because they were not just occasional users; they handled, inhaled, and absorbed these chemicals daily for years. This level of exposure strengthens the causation argument in these cases, making them some of the highest-value claims in the MDL. Additionally, their economic damages are substantial, as many of these women built careers around hairstyling, only to develop cancer and be forced to leave their industry.

Why Has There Not Been a Settlement Yet?

Defendants in major product liability lawsuits typically fight hard in the early stages to avoid setting a precedent for high settlement payouts. They also prefer to wait until more cases are past the statute of limitations before settling. The hair relaxer MDL is still in the discovery phase, with bellwether trials scheduled for 2027. However, state court trials could take place sooner, and substantial verdicts (or the possibility of them) might encourage more serious settlement negotiations.

These companies are aware of the trouble they are in but will attempt to delay the process as long as possible to minimize payouts. This strategy is a common tactic in the defendants’ mass torts playbook.

What Are the Projected Hair Relaxer Lawsuit Settlement Amounts?

Settlement values in the hair relaxer litigation will largely depend on the type of injury, with cancer claims expected to yield the highest recoveries. Uterine, ovarian, and endometrial cancer cases are often estimated to bring in the $150,000 to $750,000 range per plaintiff if the litigation proceeds as planned. These figures could increase if juries in the bellwether trials return significant verdicts.

Fibroid cases are in a different category. Few law firms are currently pursuing these claims, and they are not included in the MDL. However, the attorneys at Nguyen Injury Lawyer are taking these cases because we believe that there will be settlement value once the litigation progresses, especially in cases where fibroids led to a hysterectomy. While each claim is unique, they all represent personal tragedies that could result in meaningful settlement compensation.

More information about our thoughts on projected hair relaxer settlement payouts can be found on our website: Nguyen Injury Lawyer.

What Is the Best Defense Argument?

In some cases, women have used a variety of different products, which can complicate the matter. Some of the defendants are smaller, family-run businesses. The primary targets are major companies like L’Oréal and Revlon. Although Revlon is currently in bankruptcy, they have substantial insurance coverage for these claims.

Are Hair Relaxer Lawsuits Just Another Class Action Cash Grab?

These hair relaxer lawsuits are not frivolous class actions where individuals receive minimal compensation. These cases involve women, many of whom have used relaxers for decades, suffering from cancer, hysterectomies, and other life-altering medical conditions. The scientific evidence is compelling, and companies like L’Oréal were aware of the dangers of these chemicals but continued to sell them. This is about achieving real justice, not a quick payout.

Will Revlon’s Bankruptcy Affect Hair Relaxer Lawsuit Payouts?

Revlon is currently attempting to shield itself from liability through bankruptcy protection, a common strategy for corporations facing mass tort litigation. However, Revlon has maintained significant insurance coverage that remains available to cover valid claims. These insurance policies, issued over several years and potentially including primary and excess layers, are not discharged or negated by the bankruptcy process. As a result, plaintiffs with pending or future claims may still have a viable path to recovery through these insurance assets.

What’s the Biggest Myth About the Hair Relaxer Lawsuit?

The biggest misconception is that you do not have a strong case if you only used relaxers a few times a year. This is incorrect. The Sister Study clearly demonstrates that even low-level exposure to endocrine-disrupting chemicals has been linked to increased cancer risks. While hairstylists and frequent users may have the strongest claims, every exposure is significant.

How Do I Know If I Qualify for a Hair Relaxer Lawsuit?

If you have used chemical relaxers (including brands like Dark & Lovely, Optimum, ORS, Just for Me, Revlon, and others) and were subsequently diagnosed with uterine, ovarian, or endometrial cancer, or underwent a hysterectomy due to fibroids, you likely have a case. If you are wondering whether you qualify for a hair relaxer lawsuit, the answer is likely yes if you regularly used these products and suffered serious health consequences. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX to speak with an attorney now or visit our contact page at https://www.nguyeninjurylawyer.com/contact.

Chemical Hair Relaxers: An Overview

Hair relaxers are cosmetic products primarily used by African American women to relax, flatten, and straighten their hair.

All hair, regardless of ethnic origin, shares common characteristics in its chemical makeup and molecular structure. The hair shaft, located in the center and growing up through the follicle, emerges from the scalp as threadlike structures. These hair fibers are composed of three distinct regions: the cuticle (the outermost area consisting of lamellar layers of structural tissue), the cortex (the inner area comprising the bulk of the fiber), and the medulla (the innermost area lying at the center of the fiber).

High PH Systems

Hair relaxers are high-pH systems containing a strong alkali and are formulated as thick cream emulsions. Chemical hair relaxers are applied to the base of the hair and left in place for a specific period. The bonds found in the hair are located within the keratin proteins. The most important type of bond found in the hair is the disulfide bond, also known as the cysteine bond.

Keratin is highly sensitive to changes in the hydrogen ion concentration (or pH) of its environment. Although relatively resistant to acids, keratin can be broken down by high-pH alkali solutions. This property is precisely what is exploited during hair relaxing.

How Hair Relaxers Work

The chemicals in hair relaxers are applied to the base of the hair shaft. After the application period, the hair relaxer alters the hair’s texture by compromising the hair’s protein structure. This protein damage straightens and smooths the hair.

After a period of weeks (typically 4–8 weeks), depending on the hair’s natural growth rate, the treated portion of the hair grows away from the scalp as new growth sprouts from the roots, requiring additional relaxer treatment to smooth the roots.

These additional treatments are commonly referred to as “re-touches,” resulting in women relaxing their new growth every four to eight weeks on average, often for decades.

The application loosens the hair’s tight curls and removes its kinkiness through a chemical reaction that breaks the disulfide bonds in the hair. This potent mix of chemicals attacks the hair’s protein structure, causing it to flatten.

What makes this litigation even more critical is the near-total absence of federal oversight over the chemicals used in perms and hair straighteners. The Fair Packaging and Labeling Act requires cosmetic products to disclose their ingredients, but this mandate is riddled with loopholes, and the FDA does not actively enforce it.

A 2018 study from the Silent Spring Institute, a leading environmental health research organization, analyzed 18 hair products commonly marketed to and used by Black women. The results were concerning. These products contained dozens of hormone-disrupting chemicals, and 84 percent of the toxic ingredients were not disclosed on the packaging.

Why is this allowed? Under current law, manufacturers are not required to list individual chemicals if they are part of a fragrance or flavor blend. This means that chemicals like phthalates, which have been linked to cancer and reproductive harm, can be completely hidden as long as they are included in a proprietary fragrance mixture. This regulatory failure has serious public health consequences. If the hair relaxer lawsuits accomplish anything beyond financial accountability, they may help force long-overdue changes in how these products are labeled and regulated. Until then, consumers remain in the dark about what they are absorbing through their scalps.

Uterine Cancer

There are two different types of uterine cancer: endometrial and sarcoma. Endometrial uterine cancer is more common and treatable, while the sarcoma type is less common but more aggressive and difficult to treat.

Uterine cancer is a relatively common type of cancer, with approximately 65,000 new cases diagnosed each year in the U.S., accounting for about 3.5% of all new cancer cases annually. Around 12,500 women die from uterine cancer each year, representing about 2% of cancer-related deaths.

The overall 5-year survival rate for uterine cancer is comparatively high at 81%. However, the sarcoma type of uterine cancer is much more aggressive and has a lower survival rate.

Uterine cancer has long been associated with exposure to phthalate metabolites, chemicals commonly found in hair perm and relaxer products. This type of cancer is the fourth most common among women. In the United States, the incidence rate of uterine cancer is notably higher in Black women, who are diagnosed at twice the rate of White women.

If you have concerns about hair relaxer products, please contact Nguyen Injury Lawyer at XXX-XXX-XXXX.

Plaintiffs Allege Link Between Hair Relaxer Use and Uterine Cancer

Plaintiffs in hair relaxer lawsuits contend that the sustained use of these products, which contain harmful chemicals, contributes to the development of uterine cancer. This alleged connection highlights the critical need for enhanced regulation and the development of safer alternatives within the beauty industry to protect consumer well-being.

These lawsuits frequently reference a pivotal medical study indicating that women who use chemical hair relaxers face a heightened risk of uterine cancer. The study, published in the Journal of the National Cancer Institute in October 2022, estimated that approximately 1.64% of women who had never used these products would develop uterine cancer by age 70.

Alarmingly, the study suggests that for frequent users, this risk more than doubles, escalating to 4.05%.

Hair Relaxer Products and Ovarian Cancer Risk

Ovarian cancer is a relatively uncommon disease, with about 20,000 cases diagnosed annually in the United States, representing less than 1% of all cancer diagnoses. The five-year survival rate for ovarian cancer is approximately 47%, significantly lower than those for uterine and breast cancers.

The primary reason for this lower survival rate is that ovarian cancer often presents no noticeable symptoms in its early stages, and there are currently no straightforward screening methods available. Consequently, most cases are not diagnosed until the cancer has advanced, making treatment more challenging. The lack of early symptoms contributes significantly to delayed diagnoses.

Compelling scientific evidence suggests a link between chemical hair relaxers and increased rates of ovarian cancer. This evidence comes from the Sister Study, conducted at the National Institutes of Health (NIH). In October 2021, the NIH research team published findings in a medical journal indicating an association between the use of chemical hair relaxers and higher rates of ovarian cancer. The Sister Study showed that women who used hair relaxer products four or more times per year had a 50% higher risk of developing ovarian cancer.

See if you qualify for a hair relaxer lawsuit by contacting Nguyen Injury Lawyer at XXX-XXX-XXXX or visiting our website at https://www.nguyeninjurylawyer.com. You can also reach us through our contact page at https://www.nguyeninjurylawyer.com/contact.

Do Hair Perms Pose Similar Risks?

The potential for uterine cancer and other health issues related to hair relaxers has raised concerns about the safety of other hair treatments, including perms.

Many of the same chemicals found in hair relaxers, such as phthalates and formaldehyde-releasing agents, are also present in hair perms and straightening products. These compounds, often hidden under the labels of “fragrance” or “perfume,” are known endocrine disruptors. This means they can interfere with the body’s hormonal systems in ways that may lead to hormone-driven cancers, including uterine, ovarian, and endometrial cancers. Because both relaxers and perms contain these potentially harmful ingredients, women face similar health risks when choosing chemical-based perms.

Hair Relaxer Class Action Lawsuit Overview

Yes, there is currently an active hair relaxer class action lawsuit pending in federal court, consolidated into a multidistrict litigation (MDL) in the Northern District of Illinois. This federal litigation addresses claims that the long-term use of chemical hair relaxers and straighteners has led to serious health issues, particularly uterine cancer, ovarian cancer, and other hormone-related conditions in women.

In addition to the federal MDL, numerous state court lawsuits are proceeding independently across the country, with a significant number in Illinois. These cases share similar allegations but are managed separately from the federal system, often under state-specific regulations and timelines. Cases involving uterine fibroids and related injuries are being handled outside the MDL.

Several companies, including major brands like L’Oréal and smaller manufacturers of chemical hair relaxers, are named as defendants in these lawsuits. Plaintiffs claim that these companies failed to adequately warn consumers about the potential health risks associated with their products.

A primary concern for our clients and other victims is the timeline for a potential settlement in the hair relaxer lawsuit. While a definitive timeline is not yet available, Nguyen Injury Lawyer provides updates on our website. Settlement discussions typically begin after preliminary bellwether trials or when defendants have sufficient incentive to resolve a large number of claims through negotiated agreements.

Whether it’s referred to as a relaxer lawsuit, perm lawsuit, or hair relaxer class action lawsuit, all terms refer to the same expanding litigation aimed at holding manufacturers accountable for alleged product dangers. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or through our website at https://www.nguyeninjurylawyer.com or our contact page at https://www.nguyeninjurylawyer.com/contact for more information.

Statute of Limitations in Hair Relaxer Lawsuits

Is it too late to file a hair relaxer lawsuit? The answer depends on the applicable statute of limitations in your state. A statute of limitations is a legal deadline that restricts how long plaintiffs have to file a lawsuit. If a case is not filed before this deadline, the claim is barred, and the individual cannot sue.

Each state has its own statute of limitations for personal injury cases, including hair relaxer lawsuits. The deadline for filing a lawsuit for hair relaxer injuries varies by state. The specific statute of limitations in each of the 50 states can be found here. When considering filing a hair relaxer lawsuit, the critical factor is not just the length of the limitation period, but when it begins.

In most states, the statute of limitations starts based on the “discovery rule.” According to this common law principle, the statute of limitations does not begin until the plaintiff knows, or reasonably should know, that they have a potential lawsuit.

Scientific Evidence in Hair Relaxer Lawsuits

A crucial element in the ongoing hair relaxer lawsuits is the growing body of scientific evidence linking the use of chemical hair straighteners to hormone-related cancers, especially uterine and ovarian cancer.

Plaintiffs heavily rely on studies suggesting a strong correlation between the long-term use of hair relaxer products and an increased cancer risk, particularly for Black women who are disproportionately affected due to the frequent use of these products.

The Sister Study, conducted by the National Institutes of Health (NIH), is a key piece of evidence. This study followed over 33,000 women and found that those who used hair relaxers four or more times per year had a 2.4 times greater risk of developing uterine cancer compared to non-users. Additionally, the risk of ovarian cancer was 50% higher for frequent users of hair relaxers.

As litigation progresses, strong causation evidence will significantly influence both settlement amounts and potential jury payouts. The robust data supporting the connection between hair relaxer use and cancer is a key factor in the optimism of Nguyen Injury Lawyer regarding these cases.

Our attorneys at Nguyen Injury Lawyer are highly optimistic about the direction of these lawsuits, having been involved in this litigation for over two years. We believe the strong scientific evidence will lead to substantial settlements for victims. Whether through court victories or successful settlement negotiations, our lawyers are confident in their ability to secure justice in these claims. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or through our website at https://www.nguyeninjurylawyer.com or our contact page at https://www.nguyeninjurylawyer.com/contact for a consultation.

Potential Settlement Amounts in Hair Relaxer Uterine Cancer Lawsuits

It is still early to speculate on the potential value of hair relaxer uterine cancer lawsuits at trial or in settlement. However, after more than two years of involvement, our attorneys at Nguyen Injury Lawyer believe the scientific evidence is compelling. This is why many law firms are advertising for victims with uterine cancer or other injuries who are looking to file a hair relaxer lawsuit.

Projected Average Compensation Payouts

Our lawyers at Nguyen Injury Lawyer estimate that a strong uterine cancer case could yield an average settlement payout ranging from $150,000 to $750,000. Realistically, the average settlement amount is likely to be at the lower end of this scale. Cases involving particularly young plaintiffs could be worth significantly more, especially since uterine cancer often results in permanent infertility.

A trial verdict could result in a higher payout. Possibly much higher. Verdicts could reach hundreds of millions or even billions, as seen in the Roundup litigation involving similar injuries.

This average hair relaxer settlement amount projection should be viewed with the understanding that the hair straightener litigation is still in its early stages. It remains to be seen how strong the expert testimony will be. Nevertheless, we can still speculate on likely settlement amounts.

One significant variable is the defendants’ ability to pay. Settlement payouts in hair relaxer lawsuits will vary considerably depending on the defendants involved. L’Oréal, as a major player with substantial financial resources, has the capacity to pay fair settlements or jury awards. The company’s ability to pay is not a concern. Revlon is currently in bankruptcy but has a large insurance policy that will cover claims.

However, smaller companies in the industry may struggle to meet fair settlement values for plaintiffs, especially when faced with multiple claims. Plaintiffs with claims against less financially stable defendants may encounter more challenges in achieving the same level of compensation.

Previous Hair Relaxer Settlements and Verdicts

As of January 2026, no hair relaxer cases have gone to trial. The first trial is scheduled for 2027. In mass tort cases, settlements typically cover all plaintiffs or groups of plaintiffs, categorized by injury or individual law firms.

Available Compensation for Hair Relaxer Injuries

If you have been diagnosed with uterine, ovarian, or endometrial cancer, or required a hysterectomy due to fibroids, after prolonged use of chemical hair relaxers, you may be entitled to significant financial compensation. Compensation in these cases typically includes economic damages, noneconomic damages, and punitive damages.

Economic damages cover the measurable financial costs of your illness. This includes medical expenses for surgeries, chemotherapy, radiation, and ongoing care, as well as lost wages for those unable to work. Future earning potential can also be considered.

Noneconomic damages often constitute the largest portion of compensation in these cases. Our attorneys at Nguyen Injury Lawyer believe that the most significant harm stems from the pain and suffering endured by victims. This includes physical pain, emotional distress, the trauma of a cancer diagnosis, and the lasting impact on quality of life. For many women, the loss of fertility or permanent disfigurement, such as surgical scars, can create lifelong challenges.

Finally, punitive damages may be awarded when manufacturers act recklessly, such as by ignoring clear evidence of danger or failing to warn consumers. These damages are intended to punish the responsible companies and deter future misconduct. Punitive damages will be available in many states and will influence settlement compensation amounts when the time comes.

How Hair Relaxer Settlements Work

A hair relaxer settlement is complex due to the involvement of multiple defendants with varying degrees of responsibility. The most likely outcome is settlements reached with individual attorneys or globally, using a points-based system to fairly distribute funds among the victims. Contact Nguyen Injury Lawyer at XXX-XXX-XXXX or through our website at https://www.nguyeninjurylawyer.com or our contact page at https://www.nguyeninjurylawyer.com/contact to discuss your case.

Determining Settlement Amounts in Hair Relaxer Cancer Cases

The goal of a points-based system is to allocate settlement funds equitably, using objective criteria such as the severity of injuries, the required medical treatments, and the impact on the victim’s overall well-being. This approach is widely recognized for its structured and transparent method of determining settlement amounts in collective compensation deals. By using such a system, individuals in similar situations can receive comparable payouts.

So, what factors could lead to a higher point value and, consequently, a larger settlement? In hair relaxer cancer settlements, a points-based system would likely consider several key elements to determine the compensation for each victim. These are some of the critical factors that could influence point allocation:

• Severity of Diagnosis: The stage of cancer at the time of diagnosis would significantly impact the points awarded. Advanced stages typically receive more points due to the need for more extensive treatment and the greater impact on the victim’s quality of life.
• Extent of Medical Treatment: The type and duration of treatment, including surgery, chemotherapy, radiation therapy, and other interventions, would be taken into account. More aggressive or prolonged treatments would result in higher point values.
• Impact on Quality of Life: This includes the extent to which the cancer and its treatment have affected the individual’s daily activities, ability to work, and overall lifestyle. Pain and suffering would be a major component of this factor. Severe impacts would lead to higher points.
• Duration of Use: The length of time the victim used hair relaxers is also likely to be considered. Longer periods of use would correlate with higher point values due to increased exposure to potentially harmful chemicals.
• Age at Diagnosis: Younger victims typically receive more points because of the long-term impact on their lives, including potential loss of reproductive capabilities and other long-term health complications.
• Proof of Causation: Strong medical evidence linking the use of hair relaxers to the development of cancer in the victim would be crucial. Victims with clear and convincing evidence would receive more points.
• Economic Impact: Loss of income, medical expenses, and other financial burdens resulting from the illness would be considered. Greater financial impacts would result in more points.
• Loss of Consortium: The impact on the victim’s family life and relationships, including the ability to maintain personal and familial roles, could also be a factor.

However, a points-based settlement system has potential drawbacks. It can oversimplify complex individual experiences by reducing them to numerical values. This can lead to overlooking unique circumstances and personal impacts that a computer and a points system simply cannot calculate. Additionally, it may lead to disputes over point allocations and the subjective interpretation of criteria, causing dissatisfaction among claimants who feel their cases were not adequately represented.

Uterine Cancer Settlements and Verdicts

Below are summaries detailing settlements and jury verdicts in cases where uterine cancer was the primary injury. While these are medical malpractice cases, not product liability lawsuits, they may provide valuable context for estimating potential settlement amounts or jury payouts in chemical hair relaxer or perm litigation. These cases specifically involve claims that physicians negligently failed to diagnose uterine cancer in a timely manner, leading to harm for the plaintiffs.

The examples cited here were last updated in January 2026, with the most recent settlement occurring in 2024. This lag reflects the relative rarity of medical malpractice lawsuits related to uterine cancer. Unlike more commonly litigated cancers, such as breast or colon cancer, uterine cancer presents unique diagnostic challenges that make it less likely to result in malpractice claims. Cancers like breast and colon cancer often involve more definitive diagnostic markers, resulting in clearer cases of negligence when doctors fail to act. In contrast, uterine cancer’s diagnostic complexity can make it harder for plaintiffs to establish liability, reducing the frequency of these cases.

Despite these differences, the outcomes in these malpractice cases may serve as a valuable lens for understanding the range of damages awarded in cases involving uterine cancer, particularly as the legal community begins to evaluate claims alleging a link between chemical hair relaxer use and uterine cancer. By drawing comparisons, we gain some insight into how juries compensate for this injury.

• $9,900,000 Settlement (Washington, 2024): The Washington Department of Corrections agreed to pay $9.9 million to a former prisoner and her family. The lawsuit alleged that medical staff failed to diagnose and treat her uterine cancer, allowing the disease to progress to a terminal stage. Despite early indicators such as a positive HPV test and a uterine growth detected via ultrasound, the patient was not informed of these results, nor was she provided with necessary follow-up care. This substantial settlement underscores the severe consequences of delayed cancer diagnosis and the importance of timely medical intervention.
• $1,500,000 Settlement (Pennsylvania 2023): A 24-year-old female patient went to the defendant OB/GYN practice on numerous occasions for treatment of irregular periods, abdominal cramping, and other issues before she died from undiagnosed uterine cancer. The lawsuit claimed the defendants were negligent in failing to timely diagnose and treat the plaintiff’s cancer, failing to refer the plaintiff’s decedent to specialists, failing to order timely diagnostic tests, failing to use due care and proper skill in diagnosing and treating the plaintiff’s decedent, failing to properly examine the plaintiff’s decedent concerning her symptoms.
• $5,800,000 Verdict (Pennsylvania 2021): Failure to perform a hysterectomy or a myomectomy on a 48-year-old plaintiff from Philadelphia resulted in the spread and metastasis of uterine cancer. After a four-day trial and six hours of deliberation, a Philadelphia jury awarded a verdict against Einstein Healthcare Network for its medical negligence. The patient, initially in good health and working as a director at the Juvenile Justice Center, suffered significant deterioration in her health, leading to multiple hospitalizations due to the cancer spreading to her lungs and spine.
• $1,800,000 Settlement (Illinois 2020): Failure to diagnose uterine cancer in a 41-year-old plaintiff from Chicago resulted in a 4-year delay in treatment, allowing cancer to progress. There is a big difference between a delay in diagnosing cancer and causing cancer from a jury’s perspective. And… a doctor who makes an innocent mistake is also a more sympathetic defendant than a company that puts toxic chemicals in their product without telling anyone.
• $500,000 Settlement (Washington 2018): Failure to diagnose due to poor communication resulting in a 5-month delay of uterine cancer in a 71-year-old plaintiff with a prior history of cancer.
• $600,000 Settlement (New York 2015): Failure to send an ultrasound report caused a delay in the diagnosis of uterine cancer in a 35-year-old woman. Despite the young age of the plaintiff, the settlement amount is likely lower because she did not intend to have more children.
• $430,000 Settlement (Minnesota 2014): The doctor settled the case for allegedly failing to diagnose uterine cancer in a 60-year-old patient, resulting in a 2-year delay and progression of cancer to stage 3C.
• $1,750,000 Settlement (Massachusetts 2013): Failure to diagnose uterine cancer in a 52-year-old plaintiff resulting in the spread of cancer to the lungs and progression to the terminal stage.

There are different issues in these lawsuits – mostly medical malpractice – that you would see in a hair straightener lawsuit against L’Oréal or another one of these defendants. But malpractice cases are often hard to prove. If these claims are strong, the harm is serious, and the settlement amounts could be very high.

The attorneys at Nguyen Injury Lawyer are currently evaluating cases across the country, assessing claims individually to help victims pursue fair compensation for their suffering. If you believe your cancer diagnosis or fibroid condition could be related to these products, please contact us for a consultation to determine your eligibility. You may be entitled to compensation through settlements or potential jury payouts that reflect the harm caused by dangerous chemicals in hair relaxers.

Contact Us About Filing a Hair Relaxer Cancer Lawsuit

The lawyers at Nguyen Injury Lawyer are reviewing cases across all 50 states, assessing claims on a case-by-case basis to help victims pursue fair compensation for their suffering. If you believe your cancer diagnosis or fibroid condition could be related to these products, reach out for a consultation to determine your eligibility. You may obtain compensation through settlements or potential jury payouts that reflect the harm caused by dangerous chemicals in hair relaxers. Contact Nguyen Injury Lawyer today for a free consultation at XXX-XXX-XXXX or get a free online consultation through our contact page at https://www.nguyeninjurylawyer.com/contact.